Depo-medroxyprogesterone acetate, weight gain and amenorrhea among obese adolescent and adult women

References

• Trussell J. Contraceptive failure in the United States. Contraception 2011;83:397–404.
   PubMed Web of Science ®Google Scholar
• Jacobstein R, Polis C. Progestin-only contraception: injectables and implants. Best Pract Res Clin Obstet Gynaecol. 2014;28:795–806.
   PubMed Web of Science ®Google Scholar
• Peipert J, Zhao Q, Allsworth J, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol. 2011;117:1105–1113.
   PubMed Web of Science ®Google Scholar
• Lopez LM, Ramesh S, Chen M, et al. Progestin-only contraceptives: effects on weight. Cochrane Database Syst Rev 2016;8:CD008815.
   Google Scholar
• Ogden CL, Carroll MD, Fryar CD, et al. Prevalence of obesity among adults and youth: United States 2011-2014. NCHS Data Brief 2015;219:1–8.
   PubMedGoogle Scholar
• Hales CM, Carroll MD, Fryar CD, et al. Prevalence of obesity among adults and youth: United States, 2015-2016. NCHS Data Brief 2017;288:1–8.
   Google Scholar
• Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:1–253.
   Web of Science ®Google Scholar
• Nejat E, Polotsky A, Pal L. Predictors of chronic disease at midlife and beyond – the health risks of obesity. Maturitas 2010;65:106–111.
   PubMed Web of Science ®Google Scholar
• Harris P, Taylor R, Thielke R, et al. Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381.
   PubMed Web of Science ®Google Scholar
• Gallo MF, Lopez LM, Grimes DA, et al. Combination contraceptives: effects on weight. Cochrane Database Syst Rev. 2014;1:CD003987.
   PubMedGoogle Scholar
• Haider S, Darney P. Injectable contraception. Clin Obstet Gynecol. 2007;50:898–906.
   PubMed Web of Science ®Google Scholar
• Bonny A, Britto M, Huang B, et al. Weight gain, adiposity, and eating behaviors among adolescent females on depot medroxyprogesterone acetate (DMPA). J Pediatr Adolesc Gynecol. 2004;17:109–115.
   PubMedGoogle Scholar
• Sangkomkamhang US, Lumbiganon P, Laopaiboon M, et al. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids. Cochrane Database Syst Rev. 2013;28:CD008994.
   Google Scholar
• Venkatachalam S, Bagratee J, Moodley J. Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study. J Obstet Gynaecol. 2004;24:798–800.
   PubMedGoogle Scholar
• Fraser I, Dennerstein G. Depo-Provera use in an Australian metropolitan practice. Med J Aust. 1994;160:553–556.
   PubMed Web of Science ®Google Scholar
• Brown S, Morrison L, Larkspur L, et al. Well-being sleep, exercise patterns and the menstrual cycle: a comparison of natural hormones, oral contraceptives and Depo-Provera. Women’s Health 2008;47:105–121.
   PubMed Web of Science ®Google Scholar
• Ogilvie R, Patel S. The epidemiology of sleep and obesity. Sleep Health 2017;3:383–388.
   PubMed Web of Science ®Google Scholar
• Mangan S, Larsen P, Hudson S. Overweight teens at increased risk for weight gain while using depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol. 2002;15:79–82.
   PubMedGoogle Scholar
• Silva P, Qadir S, Fernandes A, et al. Dietary intake and eating behavior in depot medroxyprogesterone acetate users: a systematic review. Braz J Med Biol Res. 2018;51:e7575.
   PubMed Web of Science ®Google Scholar
• Vickery Z, Madden T, Zhao Q, et al. Weight change at 12 months in users of three progestin-only contraceptive methods. Contraception 2013;88:503–508.
   PubMed Web of Science ®Google Scholar
• Risser W, Gefter L, Barratt M, et al. Weight change in adolescents who used hormonal contraception. J Adolesc Health 1999;24:433–436.
   PubMed Web of Science ®Google Scholar
• Lange H, Belury M, Secic M, et al. Dietary intake and weight gain among adolescents on depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol. 2015;28:139–143.
   PubMed Web of Science ®Google Scholar
• Bonny A, Ziegler J, Harvey R, et al. Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method. Arch Pediatr Adolesc Med. 2006;160:40–45.
   PubMed Web of Science ®Google Scholar
• Bonny A, Secic M, Cromer B. A longitudinal comparison of body composition changes in adolescent girls receiving hormonal contraception. J Adolesc Health 2009;45:423–425.
   PubMed Web of Science ®Google Scholar
• Le Y, Rahman M, Berenson A. Early weight gain predicting later weight gain among depot medroxyprogesterone acetate users. Obstet Gynecol. 2009;114:279–284.
   PubMed Web of Science ®Google Scholar
• Pantoja M, Medeiros T, Baccarin M, et al. Variations in body mass index of users of depot-medroxyprogesterone acetate as a contraceptive. Contraception 2010;81:107–111.
   PubMed Web of Science ®Google Scholar
• Pantoja M, Medeiros T, Baccarin M, et al. [Variation of weight among users of the contraceptive with depot-medroxyprogesterone acetate according to body mass index in a six-year follow-up]. Rev Bras Ginecol Obstet. 2009;31:380–384.
   PubMedGoogle Scholar
• Steward R, Bateman L, Slentz C, et al. The impact of short-term depot-medroxyprogesterone acetate treatment on resting metabolic rate. Contraception 2016;93:317–322.
   PubMed Web of Science ®Google Scholar
• Berenson A, Rahman M. Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use. Am J Obstet Gynecol. 2009;200:329.e1–329.e8.
   PubMed Web of Science ®Google Scholar
• Clark M, Dillon J, Sowers M, et al. Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception. Int J Obes. 2005;29:1252–1258.
   PubMed Web of Science ®Google Scholar
• Paul C, Skegg D, Williams S. Depot medroxyprogesterone acetate. Patterns of use and reasons for discontinuation. Contraception 1997;56:209–214.
   PubMed Web of Science ®Google Scholar
• Hubacher D, Lopez L, Steiner M, et al. Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons. Contraception 2009;80:113–118.
   PubMed Web of Science ®Google Scholar
• Arias R, Jain J, Brucker C, et al. Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg. Contraception 2006;74:234–238.
   PubMed Web of Science ®Google Scholar
• Stanczyk F, Burke A, Hong K, et al. Morbid obesity: potential effects of hormonal contraception. Contraception 2018;98:174–180.
   PubMed Web of Science ®Google Scholar
• Lavie C, McAuley P, Church T, et al. Obesity and cardiovascular diseases: implications regarding fitness, fatness and severity in the obesity paradox. J Am Coll Cardiol. 2014;63:1345–1354.
   PubMed Web of Science ®Google Scholar
• Batista G, Souza A, Marin D, et al. Body composition, resting energy expenditure and inflammatory markers: impact in users of depot medroxyprogesterone acetate after 12 months’ follow-up. Arch Endocrinol Metab. 2017;61:70–75.
   PubMed Web of Science ®Google Scholar
• Berenson A, Rahman M, Wilkinson G. Effect of injectable and oral contraceptives on serum lipids. Obstet Gynecol. 2009;114:786–794.
   PubMed Web of Science ®Google Scholar
• Bakry S, Merhi Z, Scalise T, et al. Depot-medroxyprogesterone acetate: an update. Arch Gynecol Obstet. 2008;278:1–12.
   PubMed Web of Science ®Google Scholar
• Gaillard T. The metabolic syndrome and its components in African-American women: emerging trends and implications. Front Endocrinol (Lausanne) 2017;8:383.
   PubMed Web of Science ®Google Scholar